Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long‐term outcomes in 14 patients
- 7 June 2013
- journal article
- research article
- Published by Wiley in Hepatology Research
- Vol. 44 (7), 740-749
- https://doi.org/10.1111/hepr.12181
Abstract
Aim To evaluate the clinical outcomes of percutaneous transvenous embolization (PTE) for portosystemic shunt (PSS) associated with encephalopathy Methods Fourteen patients with portosystemic encephalopathy (PSE) were enrolled in this retrospective cohort study. We evaluated technical success, clinical success, complication and outcomes. Results In cases in which PSS was one of main causes of PSE, three also had splenorenal shunts, four gastrorenal shunts, four superior mesenteric vein systemic shunts, one inferior mesenteric vein systemic shunt and two main trunk of portal vein inferior vena cava shunts. We used only ethanolamine oleate (EO) in five; EO and coils in five; EO, coils and n‐butyl 2‐cyanoacrylate (NBCA) in two; and coils and NBCA in two patients as embolic materials. The rate of primary and secondary technical success was 93% (13/14 patients) and 100%, respectively. No major complications were encountered related to PTE. Follow‐up period was a median of 27 months (range, 12–79). All patients had sustained disappearance of PSE. PSE recurred in one patient because of another PSS development. Thus, clinical success was achieved in 93% (13/14 patients). The ammonia levels 1 year after PTE were significantly improved compared with pre‐PTE (median, 102 vs 41 μmol/L) and maintained lower levels 2 and 3 years later. Child–Pugh scores did not change significantly. Esophageal varices were aggravated in 29% (4/14 patients). Five patients died, but no death of hepatic failure related to PTE was encountered. Conclusion PTE could be one of the useful treatment options for PSE.Keywords
This publication has 28 references indexed in Scilit:
- Chronic Portal-SystemicShunt Encephalopathy in a Hemodialysis Patient Treated with Balloon-Occluded Retrograde Transvenous ObliterationCase Reports in Nephrology and Dialysis, 2013
- Efficacy of Balloon-occluded Retrograde Transvenous Obliteration of Large Spontaneous Lienorenal Shunt in Patients with Severe Recurrent Hepatic Encephalopathy with Foam Sclerotherapy: Initial ExperienceJournal of Vascular and Interventional Radiology, 2012
- Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomyHepatology Research, 2012
- Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiotaWorld Journal of Gastroenterology, 2012
- Treatment of Hepatic Encephalopathy Due to Inferior Mesenteric Vein/Inferior Vena Cava and Gonadal Vein Shunt Using Dual Balloon-Occluded Retrograde Transvenous ObliterationCardioVascular and Interventional Radiology, 2008
- The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliterationThe Esophagus, 2007
- Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Fundal Varices with HemorrhageAmerican Journal of Roentgenology, 2002
- Therapeutic Effect of Balloon-occluded Retrograde Transvenous Obliteration on Portal-systemic Encephalopathy in Patients with Liver Cirrhosis.Internal Medicine, 2001
- Transjugular retrograde obliteration for gastric varicesAbdominal Radiology, 1996
- Treatment of gastric fundal varices by balloon‐occluded retrograde transvenous obliterationJournal of Gastroenterology and Hepatology, 1996